| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.07 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |